APA (7th ed.) Citation

Riedl, C. C., Luft, N., Bernhart, C., Weber, M., Bernathova, M., Tea, M. M., . . . Helbich, T. H. (2015). Triple-Modality Screening Trial for Familial Breast Cancer Underlines the Importance of Magnetic Resonance Imaging and Questions the Role of Mammography and Ultrasound Regardless of Patient Mutation Status, Age, and Breast Density. Journal of clinical oncology, 33(10), 1128-1135. https://doi.org/10.1200/JCO.2014.56.8626

Chicago Style (17th ed.) Citation

Riedl, Christopher C., Nikolaus Luft, Clemens Bernhart, Michael Weber, Maria Bernathova, Muy-Kheng M. Tea, Margaretha Rudas, Christian F. Singer, and Thomas H. Helbich. "Triple-Modality Screening Trial for Familial Breast Cancer Underlines the Importance of Magnetic Resonance Imaging and Questions the Role of Mammography and Ultrasound Regardless of Patient Mutation Status, Age, and Breast Density." Journal of Clinical Oncology 33, no. 10 (2015): 1128-1135. https://doi.org/10.1200/JCO.2014.56.8626.

MLA (9th ed.) Citation

Riedl, Christopher C., et al. "Triple-Modality Screening Trial for Familial Breast Cancer Underlines the Importance of Magnetic Resonance Imaging and Questions the Role of Mammography and Ultrasound Regardless of Patient Mutation Status, Age, and Breast Density." Journal of Clinical Oncology, vol. 33, no. 10, 2015, pp. 1128-1135, https://doi.org/10.1200/JCO.2014.56.8626.